source
- AI drug repurposing in oncology hampered by fragmented data, curated knowledge neededAI tools are being used to look for new cancer indications for existing biologics, but the article notes that fragmented and disparate data sets limit even the most advanced models. Repurposing pr…
- Bristol Myers shows modest revenue rise, Biogen beats forecasts, Regeneron outlook remains uncertainBioPharma Dive highlighted the latest quarterly earnings from three major biotech firms, noting how investors are interpreting the results. Bristol Myers Squibb reported $11.5 billion in revenue f…